Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/13826| Title: | Pharma's kryptonite |
| Other Titles: | Editorial [The Synapse, 13(1)] |
| Authors: | Ellul, Ian C. |
| Keywords: | Pharmaceutical industry |
| Issue Date: | 2014 |
| Publisher: | Medical Portals Ltd. |
| Citation: | Ellul, Ian, C. (2014). Pharma's kryptonite. The Synapse, 13(1), 5 |
| Abstract: | Editorial regarding the pharmaceutical industry. 2014 will herald existing and new challenges for the pharmaceutical industry. Diminishing pipelines, increasing development costs, generic competition... pharmaceutical companies are under constant pressure to innovate and collaborate if they want to survive. As a point of fact, over 700 biotechnology and pharma takeovers have occurred in the past four years |
| URI: | https://www.um.edu.mt/library/oar//handle/123456789/13826 |
| Appears in Collections: | The Synapse, Volume 13, Issue 1 The Synapse, Volume 13, Issue 1 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Pharma's kryptonite - editorial.pdf | 154.3 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.